196 related articles for article (PubMed ID: 21106720)
1. Decreased hepatic breast cancer resistance protein expression and function in multidrug resistance-associated protein 2-deficient (TR⁻) rats.
Yue W; Lee JK; Abe K; Sugiyama Y; Brouwer KL
Drug Metab Dispos; 2011 Mar; 39(3):441-7. PubMed ID: 21106720
[TBL] [Abstract][Full Text] [Related]
2. An experimental approach to evaluate the impact of impaired transport function on hepatobiliary drug disposition using Mrp2-deficient TR- rat sandwich-cultured hepatocytes in combination with Bcrp knockdown.
Yang K; Pfeifer ND; Hardwick RN; Yue W; Stewart PW; Brouwer KL
Mol Pharm; 2014 Mar; 11(3):766-75. PubMed ID: 24410402
[TBL] [Abstract][Full Text] [Related]
3. Knocking down breast cancer resistance protein (Bcrp) by adenoviral vector-mediated RNA interference (RNAi) in sandwich-cultured rat hepatocytes: a novel tool to assess the contribution of Bcrp to drug biliary excretion.
Yue W; Abe K; Brouwer KL
Mol Pharm; 2009; 6(1):134-43. PubMed ID: 19105722
[TBL] [Abstract][Full Text] [Related]
4. Hepatic basolateral efflux contributes significantly to rosuvastatin disposition II: characterization of hepatic elimination by basolateral, biliary, and metabolic clearance pathways in rat isolated perfused liver.
Pfeifer ND; Bridges AS; Ferslew BC; Hardwick RN; Brouwer KL
J Pharmacol Exp Ther; 2013 Dec; 347(3):737-45. PubMed ID: 24080682
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular exposure of troglitazone metabolites in rat sandwich-cultured hepatocytes lacking Bcrp and Mrp2: interplay between formation and excretion.
Yang K; Brouwer KL
Drug Metab Dispos; 2014 Jul; 42(7):1219-26. PubMed ID: 24799397
[TBL] [Abstract][Full Text] [Related]
6. Involvement of multidrug resistance-associated protein 2 (Abcc2) in molecular weight-dependent biliary excretion of beta-lactam antibiotics.
Kato Y; Takahara S; Kato S; Kubo Y; Sai Y; Tamai I; Yabuuchi H; Tsuji A
Drug Metab Dispos; 2008 Jun; 36(6):1088-96. PubMed ID: 18339814
[TBL] [Abstract][Full Text] [Related]
7. Involvement of BCRP (ABCG2) in the biliary excretion of pitavastatin.
Hirano M; Maeda K; Matsushima S; Nozaki Y; Kusuhara H; Sugiyama Y
Mol Pharmacol; 2005 Sep; 68(3):800-7. PubMed ID: 15955871
[TBL] [Abstract][Full Text] [Related]
8. In vitro biliary clearance of angiotensin II receptor blockers and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in sandwich-cultured rat hepatocytes: comparison with in vivo biliary clearance.
Abe K; Bridges AS; Yue W; Brouwer KL
J Pharmacol Exp Ther; 2008 Sep; 326(3):983-90. PubMed ID: 18574002
[TBL] [Abstract][Full Text] [Related]
9. Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2.
Johnson DR; Habeebu SS; Klaassen CD
Toxicol Sci; 2002 Mar; 66(1):16-26. PubMed ID: 11861969
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of (99m)technetium-mebrofenin and (99m)technetium-sestamibi as specific probes for hepatic transport protein function in rat and human hepatocytes.
Swift B; Yue W; Brouwer KL
Pharm Res; 2010 Sep; 27(9):1987-98. PubMed ID: 20652625
[TBL] [Abstract][Full Text] [Related]
11. Multiple mechanisms are involved in the biliary excretion of acetaminophen sulfate in the rat: role of Mrp2 and Bcrp1.
Zamek-Gliszczynski MJ; Hoffmaster KA; Tian X; Zhao R; Polli JW; Humphreys JE; Webster LO; Bridges AS; Kalvass JC; Brouwer KL
Drug Metab Dispos; 2005 Aug; 33(8):1158-65. PubMed ID: 15860656
[TBL] [Abstract][Full Text] [Related]
12. Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats.
Xiong H; Turner KC; Ward ES; Jansen PL; Brouwer KL
J Pharmacol Exp Ther; 2000 Nov; 295(2):512-8. PubMed ID: 11046083
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptor regulates expression of MRP2 but not that of MDR1 and BCRP in the liver.
Chisaki I; Kobayashi M; Itagaki S; Hirano T; Iseki K
Biochim Biophys Acta; 2009 Nov; 1788(11):2396-403. PubMed ID: 19728987
[TBL] [Abstract][Full Text] [Related]
14. Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats.
Kuroda M; Kobayashi Y; Tanaka Y; Itani T; Mifuji R; Araki J; Kaito M; Adachi Y
J Gastroenterol Hepatol; 2004 Feb; 19(2):146-53. PubMed ID: 14731123
[TBL] [Abstract][Full Text] [Related]
15. Hepatobiliary disposition of thyroid hormone in Mrp2-deficient TR- rats: reduced biliary excretion of thyroxine glucuronide does not prevent xenobiotic-induced hypothyroidism.
Lecureux L; Dieter MZ; Nelson DM; Watson L; Wong H; Gemzik B; Klaassen CD; Lehman-McKeeman LD
Toxicol Sci; 2009 Apr; 108(2):482-91. PubMed ID: 19211616
[TBL] [Abstract][Full Text] [Related]
16. Gene-by-Environment Interaction of Bcrp
Toth EL; Li H; Dzierlenga AL; Clarke JD; Vildhede A; Goedken M; Cherrington NJ
Drug Metab Dispos; 2018 Nov; 46(11):1478-1486. PubMed ID: 30166404
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.
Ahmed S; Vo NT; Thalhammer T; Thalhammer F; Gattringer KB; Jäger W
J Pharm Pharmacol; 2008 Jan; 60(1):55-62. PubMed ID: 18088505
[TBL] [Abstract][Full Text] [Related]
18. Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice.
Tian X; Li J; Zamek-Gliszczynski MJ; Bridges AS; Zhang P; Patel NJ; Raub TJ; Pollack GM; Brouwer KL
Antimicrob Agents Chemother; 2007 Sep; 51(9):3230-4. PubMed ID: 17576841
[TBL] [Abstract][Full Text] [Related]
19. Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat.
Zamek-Gliszczynski MJ; Hoffmaster KA; Humphreys JE; Tian X; Nezasa K; Brouwer KL
J Pharmacol Exp Ther; 2006 Oct; 319(1):459-67. PubMed ID: 16857726
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of biliary excretion of cefditoren and the effects of cefditoren on the expression levels of hepatic transporters.
Meng Q; Liu Q; Wang C; Sun H; Kaku T; Kato Y; Liu K
Drug Metab Pharmacokinet; 2010; 25(4):320-7. PubMed ID: 20814152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]